Conflict of interest : The authors declare that they have no conflicts of interest in relation to this manuscript.

Financial support : The authors received no specific funding for this work.

Authorship : All authors contributed to the manuscript, revised and edited.

Acknowledgements : The authors recognize Dr. Anna Globinska for graphical abstract design and Dr. Rodrigo Jiménez-Saiz for critical review of the manuscript.

References :

1.- Epp A, Sullivan KC, Herr AB, Strait RT. Immunoglobulin Glycosylation Effects in Allergy and Immunity. Curr Allergy Asthma Rep. 2016;16(11):79.

2.- Shade KT, Conroy ME, Anthony RM. IgE Glycosylation in Health and Disease. Curr Top Microbiol Immunol. 2019;423:77-93.

3.- Arnold JN, Radcliffe CM, Wormald MR, et al. The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin. J Immunol. 2004;173(11):6831-6840.

4.- Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol. 2008;8(3):205-217. 5.- Niki T, Tsutsui S, Hirose S, et al. Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation. J Biol Chem. 2009;284(47):32344-32352.

6.- Shade KT, Platzer B, Washburn N, et al. A single glycan on IgE is indispensable for initiation of anaphylaxis. J Exp Med. 2015 Apr 6;212(4):457-67.

7.- Shade KC, Conroy ME, Washburn N, et al. Sialylation of immunoglobulin E is a determinant of allergic pathogenicity. Nature. 2020;582(7811):265-270.

8.- Petry J, Rahmöller J, Dühring L, et al. Enriched blood IgG sialylation attenuates IgG-mediated and IgG-controlled-IgE-mediated allergic reactions. J Allergy Clin Immunol. 2020 Jun 27:S0091-6749(20)30887-3.

9.- Crawford G, Hayes MD, Seoane RC, et al. Epithelial damage and tissue γδ T cells promote a unique tumor-protective IgE response. Nature Immunology. 2018 Aug;19(8):859-870.